Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...

LogiCare3PL is proud to support the commercial launch of VYKAT™ XR, Soleno Therapeutics' newly FDA-approved therapy and the first and only treatment indicated for hyperphagia in patients with ...

Soleno has established a comprehensive support program, Soleno ONE™, to assist patients, caregivers and healthcare providers ...

Please see the full Prescribing Information, including Medication Guide. About Soleno Therapeutics, Inc. Soleno is focused on the development and commercialization of novel therapeutics for the ...

REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare ...

Piper Sandler reiterated an Overweight rating and a $93.00 price target on Soleno Therapeutics Inc. (NASDAQ:SLNO) shares, ...

REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Soleno Therapeutics (SLNO – Research Report), with a ...

Soleno Therapeutics Inc. (NASDAQ:SLNO), a $3.2 billion market cap company specializing in electromedical and electrotherapeutic apparatus, announced a change in its independent registered public ...